Table 2 The clinical parameters of the training set and the test set are shown in
Variable | Training set (n = 124) | Test set (n = 82) | P |
|---|---|---|---|
Age(years) | 50.00 (43.00–56.00) | 52.50 (46.00–59.00) | 0.114 |
BMI | 22.69 (20.25–25.19) | 22.03 (19.92–24.20) | 0.161 |
Maximum diameter of tumor (mm) | 80.00 (53.00–105.00) | 94.50 (57.00–115.00) | 0.124 |
CEA (ng/ml) | 1.70 (0.90–2.60) | 1.71 (1.12–2.89) | 0.431 |
CA125 (IU/ml) | 692.00 (164.50–1384.6) | 561.70 (143.50–1296.5) | 0.431 |
CA153 (IU /ml) | 34.54 (15.50–72.20) | 36.35 (16.36–95.05) | 0.776 |
CA199 (IU/ml) | 12.28 (4.32–108.44) | 17.32 (4.24–73.34) | 0.694 |
SCC (ng/L) | 0.70 (0.50–1.10) | 0.60 (0.50–1.20) | 0.830 |
HCG (mIU/ml) | 0.56 (0.10–1.88) | 1.02 (0.10–2.14) | 0.149 |
HE4 | 172.70 (76.10–498.50) | 159.60 (73.20–519.90) | 0.602 |
AFP(ng/ml) | 2.34 (1.79–3.27) | 2.43 (1.58–3.35) | 0.983 |
pre ROMA | 69.33 (19.41–96.68) | 60.97 (18.34–97.53) | 0.630 |
post ROMA | 79.61 (46.90–99.96) | 76.96 (45.97–99.84) | 0.502 |
Menopausal.state # | 0.993 | ||
NO | 53 (42.75) | 35 (42.68) | |
YES | 71 (57.25) | 47 (57.32) | |
Ascites # | 0.309 | ||
NO | 45 (36.29) | 36 (43.90) | |
YES | 79 (63.71) | 46 (56.10) | |
Figo stage # | 0.106 | ||
I-II | 50 (40.32) | 24 (29.27) | |
III-IV | 74 (59.68) | 58 (70.73) |